Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons from Adult Common Marmoset Fibroblasts

Scott C Vermilyea1,2, Scott Guthrie2, Michael Meyer2

  • 11 Neuroscience Training Program, University of Wisconsin-Madison , Madison, Wisconsin.

Insights

Common marmoset induced pluripotent stem cells (Cj-iPSCs) were developed from fibroblasts. These Cj-iPSCs can differentiate into all three embryonic germ layers and neural lineages, offering a new model for Parkinson's disease research.

Area of Science:

  • Stem cell biology
  • Neuroscience
  • Primate models

Background:

  • The common marmoset (Callithrix jacchus) is a valuable nonhuman primate model for age-related neurological disorders like Parkinson's disease due to its shorter lifespan.
  • Induced pluripotent stem cells (iPSCs) are crucial for in vitro disease modeling and regenerative medicine strategies.

Purpose of the Study:

  • To develop and characterize a novel common marmoset induced pluripotent stem cell (Cj-iPSC) line.
  • To assess the neural differentiation potential of Cj-iPSCs, specifically towards dopaminergic phenotypes.

Main Methods:

  • Generation of Cj-iPSCs from adult marmoset fibroblasts.
  • In vivo teratoma formation and in vitro differentiation assays to assess pluripotency.
  • Dual-SMAD inhibition combined with CHIR99021 and sonic hedgehog (SHH) treatment for neural differentiation.
  • Gene expression analysis of pluripotency markers and neural lineage-specific genes.

Main Results:

  • A novel Cj-iPSC line was successfully established and demonstrated robust pluripotency, differentiating into ectoderm, endoderm, and mesoderm lineages.
  • Cj-iPSCs expressed key pluripotency genes (e.g., OCT4, SOX2, NANOG).
  • Neural differentiation protocols yielded ventralized midbrain dopaminergic progenitors, confirmed by expression of FOXA2, OTX2, EN-1, and tyrosine hydroxylase.

Conclusions:

  • Established Cj-iPSCs serve as a versatile platform for regenerative medicine research.
  • These stem cells are suitable for modeling neurodegenerative diseases, particularly those affecting the dopaminergic system, like Parkinson's disease.